Delivery Order SPE2DR25D2014-SPE2DR26FA1E8
- Not listed
- The Defense Logistics Agency awarded a $5,970.88 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units) with an ultimate completion date of December 5, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters and primary distribution center for...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,923.54 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger contract vehicle,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units) with a ceiling value of $3,676.00. This firm fixed-price delivery order, which is set to be completed by December 10, 2025, represents a pediatric and adult neurological medication used primarily for seizure management and mood disorders. The award was competitively procured without any small business set-aside...
- The Defense Logistics Agency awarded a $16,858.83 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Oxcarbazepine ER 300 mg tablets in quantities of 100 units. The contract represents a firm fixed price delivery order with an ultimate completion date of October 22, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count packaging) under a firm fixed-price contract valued at $7,215.32. The award, which must be completed by September 18, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a $2,043.54 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Oxcarbazepine ER 600 mg tablets in quantities of 100 units. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of July 9, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a small-value pharmaceutical transaction...
- The Defense Logistics Agency awarded a delivery order valued at $1,958.79 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 mL suspension in 250 mL quantities. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded on September 3, 2025, with an ultimate completion date of September 4, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,427.33 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 ml suspension in a 250 ml container. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by December 3, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,647.46 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Oxcarbazepine 150 mg, an anticonvulsant medication commonly used to treat neurological conditions. This firm fixed-price delivery order, issued on September 22, 2025, with completion expected by September 23, 2025, represents a non-competitive set-aside purchase that leverages AmerisourceBergen's existing contract vehicle with DLA. The contractor will...
- The Defense Logistics Agency awarded a $1,725.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), an anticonvulsant medication used to treat neurological conditions. The delivery order, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA1E8Delivery Order
The Defense Logistics Agency awarded a $5,056.99 delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of January 6, 2026, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains operations as a primary pharmaceutical distributor for federal medical procurement needs. This delivery order falls within AmerisourceBergen's extensive portfolio of pharmaceutical supply contracts supporting the Defense Health Agency and military healthcare systems. The company holds a $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX) that extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle enabling the delivery of branded and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The Oxcarbazepine order exemplifies the company's role in supplying neurological treatment medications to support federal military and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 1/4/26 |